JAZZ vs OLED · P/E 1988, rev $4.07B vs P/E 33, rev $647.7M
Jazz Pharmaceuticals PLC (JAZZ) versus Universal Display (OLED) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Universal Display (OLED) is a electronic components company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported OLED revenue for 2024-12-31 was $647.7M. Net income was $222.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
Not investment advice. Open the JAZZ and OLED stock pages for the full models.
Not investment advice.